KJMC Corporate Advisors (India) Limited has announced a board meeting scheduled for February 11, 2026, to consider the company's quarterly financial results. The meeting notice was communicated to BSE Limited on February 04, 2026, in compliance with regulatory requirements.

Board Meeting Agenda

The board meeting has been scheduled to address specific business items as outlined in the regulatory filing. The primary agenda includes consideration of the company's financial performance for the recent quarter.

Financial Results Consideration

The board will review and approve the unaudited standalone and consolidated financial results along with the limited review report from statutory auditors. The results cover the quarter and nine months ended December 31, 2025, representing the company's Q3FY26 performance.

Trading Window Restrictions

In accordance with the company's internal code of conduct, trading restrictions have been implemented for market integrity. The trading window closure affects all categories of restricted persons and their immediate relatives.

Regulatory Compliance

The meeting notice was issued pursuant to Regulation 29 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company maintains its registered office at 162, 16th Floor, Atlanta, Nariman Point, Mumbai, and trades on BSE Limited under scrip code 532304.

KJMC Corporate Advisors (India) Limited has announced the resignation of its Company Secretary & Compliance Officer, Ms. Silvi Biharilal Agrawal, effective January 31, 2026. The resignation was submitted with immediate effect from the closure of business hours on January 31, 2026, citing health conditions as the primary reason for her departure.

Resignation Details

Ms. Silvi Biharilal Agrawal, holding membership number A77951, served as the Company Secretary & Compliance Officer and was designated as Key Managerial Personnel of the company. Her resignation letter, dated January 31, 2026, specifically mentioned health conditions as the reason for stepping down from her position.

Regulatory Compliance

The company has fulfilled its regulatory obligations by filing the necessary disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The disclosure was submitted to BSE Limited, where the company trades under scrip code 532304. The resignation letter will be presented to the Board of Directors for noting in the ensuing board meeting.

Transition Process

In her resignation letter, Ms. Agrawal expressed gratitude to the Board Members, senior management, and colleagues for their cooperation and support during her tenure. She also requested the company to inform BSE Limited and submit the necessary forms with the Registrar of Companies, Mumbai, ensuring proper regulatory compliance during the transition.

The company's Whole-time Director, Girish Jain (DIN: 00151673), signed the regulatory filing on January 31, 2026, confirming the acceptance of the resignation and the initiation of necessary procedural requirements.